Alpha DNA Investment Management’s ExxonMobil XOM Stock Holding History

Alpha DNA Investment Management’s Portfolio XOM Stock Details XOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,168	Closed	-$2.38M	–	184
2024 Q4	$2.38M	Buy	22,168 +8,489	+62%	+$993K	0.91%	13
2024 Q3	$1.6M	Sell	13,679 -5,542	-29%	-$640K	0.6%	36
2024 Q2	$2.21M	Buy	19,221 +234	+1%	+$27.3K	0.86%	17
2024 Q1	$2.21M	Buy	18,987 +1,759	+10%	+$184K	0.82%	16
2023 Q4	$1.72M	Buy	17,228 +5,775	+50%	+$607K	0.67%	30
2023 Q3	$1.35M	Sell	11,453 -11,138	-49%	-$1.22M	0.55%	35
2023 Q2	$2.42M	Buy	22,591 +2,749	+14%	+$300K	0.81%	13
2023 Q1	$2.18M	Buy	19,842 +1,468	+8%	+$162K	0.64%	14
2022 Q4	$2.03M	Sell	18,374 -19,176	-51%	-$2.05M	0.72%	11
2022 Q3	$3.28M	Buy	+37,550	New	+$3.43M	2.72%	1
2022 Q2	–	Sell	-17,236	Closed	-$1.42M	–	180
2022 Q1	$1.42M	Buy	+17,236	New	+$1.34M	1%	20
2021 Q2	–	Sell	-1,259	Closed	-$69K	–	675
2021 Q1	$69K	Sell	1,259 -417	-25%	-$21.9K	0.08%	140
2020 Q4	$69K	Buy	+1,676	New	+$62.8K	0.07%	146

Other funds holding XOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha DNA Investment Management's XOM Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of ExxonMobil (XOM) in Q1 2025, closing a stake of 22,168 shares — an estimated $2.38M sold.

Alpha DNA Investment Management first reported a position in XOM in Q4 2020 and held it in 13 quarters. The position peaked at $3.28M in Q3 2022. 4,258 funds tracked by Wall St. Rank hold XOM as of Q1 2025.

Alpha DNA Investment Management reported no remaining ExxonMobil position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 22,168 ExxonMobil shares in Q1 2025, an estimated $2.38M.
Alpha DNA Investment Management first reported a position in ExxonMobil in Q4 2020 and held it in 13 quarters.
Alpha DNA Investment Management's ExxonMobil position peaked at $3.28M in Q3 2022.
4,258 funds tracked by Wall St. Rank held ExxonMobil as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.